Abeona Therapeutics gets additional 180-day to regain Nasdaq compliance

Abeona Therapeutics (NASDAQ:ABEO) has been granted additional 180-day by Nasdaq to regain compliance with the $1.00 minimum bid price requirement for continued listing.
Common stock continues to trade on the Nasdaq Capital Market under the symbol "ABEO."
Nasdaq will provide the company with written confirmation of compliance if the closing bid price of its common stock is at or above $1.00/share for a minimum of ten consecutive trading days at any time until Nov. 14, 2022
The stock will be subject to delisting if compliance cannot be demonstrated during that period.
In order to to regain compliance, Abeona (ABEO) plans to seek approval of a reverse stock split of the outstanding shares of common stock at an upcoming Special Meeting of stockholders.
ABEO shares up 1.48% pre-market